🇺🇸
United States · US · US:0074-2320_6c4bad0a-5930-4bb7-8509-6a8c6f279082
Rinvoq
Orange BookUNIISPLATC L04AF03
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAbbVie Inc.
CountryUS (United States)
ATC codeL04AF03
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1100742320011 BOTTLE in 1 CARTON (0074-2320-01) / 180 mL in 1 BOTTLE
- ndc1100742320701 BOTTLE in 1 CARTON (0074-2320-70) / 180 mL in 1 BOTTLE
Annotations
UNII (FDA Substance ID)
4RA0KN46E0
UPADACITINIB
RxCUI 2196092
Orange Book
N218347
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "4RA0KN46E0",
"rxcui": "2196092",
"inchikey": "WYQFJHHDOKWSHR-MNOVXSKESA-N",
"display_name": "UPADACITINIB",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"2966aec7-2ef0-923c-d8ff-fe1a957bf095": {
"match": "brand_token",
"title": "RINVOQ (UPADACITINIB) TABLET, EXTENDED RELEASE RINVOQ (UPADACITINIB) SOLUTION [ABBVIE INC.]",
"spl_version": "100",
"published_date": "2026-04-30"
}
},
"productid": "0074-2320_6c4bad0a-5930-4bb7-8509-6a8c6f279082",
"productndc": "0074-2320",
"dosage_form": "SOLUTION",
"orange_book": {
"appl_no": "218347",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "1MG/ML",
"product_no": "001",
"approval_date": "Apr 26, 2024"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "UPADACITINIB",
"proprietary_name": "Rinvoq",
"active_ingred_unit": "mg/mL",
"application_number": "NDA218347",
"marketing_category": "NDA",
"nonproprietary_name": "Upadacitinib",
"start_marketing_date": "20240426",
"active_numerator_strength": "1"
}Related drugs
Other records sharing ATC code L04AF03.
Access this data programmatically
Query Rinvoq and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.